Kymera Therapeutics, Inc. · NASDAQ:KYMR
FMR LLC reported a 8.20% stake in Kymera Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 5, 2025
FMR LLC reported a 8.20% stake in Kymera Therapeutics, Inc., 5,879,611 shares, as a passive investor on Sep 30, 2025. Filed Nov 5, 2025 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 5,879,611
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 8.20% | 5,879,611 |
| Abigail P. Johnson | 8.20% | 5,879,611 |
Source
Related
- Kymera Therapeutics, Inc.
- FMR LLC
- Kymera Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Jan 8, 2026
- Schedule 13G/A · FMR LLC · May 12, 2025
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026